RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trialDaniel Martin, Emmanouil Fokas, Chiara Valentini et al.|Clinical and Translational Radiation Oncology|2020Cited by 33
Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysisJiadai Zou, Nils H. Nicolay, Alexander Rühle et al.|Radiation Oncology|2025Cited by 2